For queries relating to publications, please contact: CPEadmin@zoo.cam.ac.uk
-
Mühlemann, B., Trimpert, T., Walper, F., Schmidt M. L., Jenny Jansen, J., Schroeder, S., Jeworowski, L. M., Beheim-Schwarzbach, J., Bleicker, T., Niemeyer, D., Richter, A., Adler, J.M., Vidal, R. M., Langner, C., Vladimirova, D., Wilks, S. H., Smith, D. J., Voß, M., Paltrow, L., Christophersen, C. M., Rose, R., Krumbholz, A., Jones, T. C., Corman, V. M., Drosten, C. (2024) Antigenic Cartography Using Variant-Specific Hamster Sera Reveals Substantial Antigenic Variation among Omicron Subvariant. Proceedings of the National Academy of Sciences 121, no. 32 (6 August 2024): e2310917121. doi:10.1073/pnas.2310917121
-
Kok, A., Wilks, S. H., Türeli, S., James, S. J., Bestebroer, T. M., Burke, D. F., Funk M., van der Vliet, S., Spronken, M. I., Rijmink, W. F., Pattinson, D., de Meulder, D., Rosu, M. E., Lexmond, P., van den Brand, J. M. A., Herfst, S., Smith, D. J., Voucher, R. A. M., Richard, M. (2024). A Vaccine Antigen Central in Influenza A(H5) Virus Antigenic Space Confers Subtype-Wide Immunity. bioRxiv. doi:10.1101/2024.08.06.606696
-
Rössler, A., Netzl, A., Knabl L., Wilks, S. H., Mühlemann B., Türeli S, Mykytyn, A., von Laer, D., Haagmans, B. L., Smith, D. J., Kimpel, J. (2024). Direct Comparison of SARS-CoV-2 Variant Specific Neutralizing Antibodies in Human and Hamster Ser’. Npj Vaccines 9, no. 1: 1–4. doi:10.1038/s41541-024-00888-y
-
Mühlemann, B., Wilks, S. H., Baracco, L., Bekliz, M., Carreño, J. M., Corman, V. M., Davis-Gardner, M. E., Dejnirattisai, W., Diamond, M. S., Douek, D. C., Drosten, C., Eckerle, I., Edara, V.-V., Ellis, M., Fouchier, R. A. M., Frieman, M., Godbole, S., Haagmans, B., Halfmann, P. J., … Smith, D. J. (2024). Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays. Science Translational Medicine, 16(747), eadl1722. doi:10.1126/scitranslmed.adl1722
-
Gupta, R., Abdullahi, A., Onyemata, J., Turner, S., Edun, M., Kramner, A., Sievers, B., Cheng, M., Morse, R., Abdullahi, H., Okpokoro, E., Osawe, S., Kida, I., Aliyu, S., Meng, B., Döffinger, R., Smith, D., & Abimuku, A. (2024). Immune imprinting revealed by SARS-CoV-2 Omicron infection prior to vaccination. doi:10.21203/rs.3.rs-4186317/v1
-
Turner, S., Amirthalingam, G., Bailey, D., Barouch, D. H., Bewley, K. R., Brown, K., Cao, Y., Chan, Y.-W., Charlton, S., Consortium, D., Coombes, N. S., Hallis, B., Ho, D. D., Jian, F., Lasrado, N., Lassaunière, R., Liu, L., Montefiori, D. C., Moss, P., … Smith, D. J. (2024). Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA.2.86 (p. 2024.03.27.586820). bioRxiv. doi:10.1101/2024.03.27.586820
-
Fan, S., Kong, H., Babujee, L., Presler, R., Jester, P., Burke, D., Pattinson, D., Barr, I., Smith, D., Neumann, G., & Kawaoka, Y. (2024). Assessment of the antigenic evolution of a clade 6B.1 human H1N1pdm influenza virus revealed differences between ferret and human convalescent sera. eBioMedicine, 101. doi:10.1016/j.ebiom.2024.105013
- Escalera, A., Laporte, M., Turner, S., Karakus, U., Gonzalez-Reiche, A. S., van de Guchte, A., Farrugia, K., Khalil, Z., van Bakel, H., Smith, D., García-Sastre, A., & Aydillo, T. (2024). The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity. Emerging Microbes & Infections, 13(1), 2297553. doi:10.1080/22221751.2023.2297553